In this episode of Founders’ Tales, we sit down with Carlos Ezio Garciamendez, Co-Founder of Criocore, a Boston based biotech startup using bioprinting technology to improve pre clinical drug development.
Carlos shares how Criocore is building in vitro tissue models designed to better reflect human biology and reduce reliance on animal testing. The conversation explores Criocore’s academic roots at Harvard Medical School, the shift from research to commercialization, and why founders must constantly answer the question of real world impact.
They discuss fundraising realities in biotech, the importance of focusing on commercial value alongside scientific innovation, and how Boston’s competitive ecosystem pushes startups to build technologies that truly matter. Carlos also shares practical advice for first time founders, including total commitment, learning the business fundamentals, and staying focused on pilots, customers, and repeatable growth.
